NCT00473330View on ClinicalTrials.gov

A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)

PHASE3CompletedINTERVENTIONAL
Enrollment

377

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2012

Conditions
Diabetes MellitusMacular Edema
Interventions
DRUG

Ranibizumab

Sterile solution for intravitreal injection.

DRUG

Sham injection

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY

NCT00473330 - A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE) | Biotech Hunter | Biotech Hunter